Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in a patient with graft-versus-host disease

被引：0

作者：

Kuhnowski F. ^{[1
]}

Terriou L. ^{[1
]}

Magro L. ^{[1
]}

Jouet J.-P. ^{[1
]}

Yakoub-Agha I. ^{[1
]}

机构：

[1] Service des Maladies du Sang, UAM Allogreffes de CSH, CHRU, Lille

来源：

Drugs | 2006年 / 66卷 / Suppl 2期

关键词：

Imatinib; Tacrolimus; Chronic Myeloid Leukaemia; Mycophenolate Mofetil; Busulfan;

D O I：

10.2165/00003495-200666002-00009

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用

页码：29 / 31

页数：2

共 50 条

[11] Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium After Simultaneous Pancreas-Kidney Transplantation [J].

Rangel, E. B. ;

Melaragno, C. S. ;

Sa, J. R. ;

Gonzalez, A. M. ;

Linhares, M. M. ;

Salzedas, A. ;

Medina-Pestana, J. O. .

TRANSPLANTATION PROCEEDINGS, 2009, 41 (10) :4265-4269

[12] Pharmacodynamic monitoring of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable kidney-allograft recipients [J].

Boehler, Torsten ;

Canivet, Cindy ;

Galvani, Sylvain ;

Therville, Nicole ;

Salvayre, Robert ;

Negre-Salvayre, Anne ;

Durand, Dominique ;

Thomsen, Mogens ;

Rostaing, Lionel ;

Kamar, Nassim .

INTERNATIONAL IMMUNOPHARMACOLOGY, 2008, 8 (05) :769-773

[13] Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus [J].

Doukaki, Spyridoula ;

Platamone, Andrea ;

Alaimo, Roberta ;

Bongiorno, Maria Rita .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (01) :67-72

[14] Enteric-Coated Mycophenolate SodiumTolerability Profile Compared with Mycophenolate Mofetil [J].

Matthias Behrend ;

Felix Braun .

Drugs, 2005, 65 :1037-1050

[15] Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil [J].

Arns, W ;

Breuer, S ;

Choudhury, S ;

Taccard, G ;

Lee, J ;

Binder, V ;

Roettele, J ;

Schmouder, R .

CLINICAL TRANSPLANTATION, 2005, 19 (02) :199-206

[16] Enteric-coated Mycophenolate Sodium (myfortic®): An Overview of Current and Future Use in Transplantation [J].

Bruce Kaplan .

Drugs, 2006, 66 (Suppl 2) :1-8

[17] Improved gastrointestinal symptom burden after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in kidney transplanted children [J].

Pape, Lars ;

Ahlenstiel, Thurid ;

Kreuzer, Martin ;

Ehrich, Jochen H. H. .

PEDIATRIC TRANSPLANTATION, 2008, 12 (06) :640-642

[18] Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus [J].

Djabarouti, Sarah ;

Duffau, Pierre ;

Lazaro, Estibaliz ;

Chapouly, Candice ;

Greib, Carine ;

Viallard, Jean-Francois ;

Pellegrin, Jean-Luc ;

Saux, Marie-Claude ;

Breilh, Dominique .

EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (05) :689-699

[19] Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats [J].

Jia, Yichen ;

Wang, Rulin ;

Li, Long ;

Zhang, Ying ;

Li, Jiawei ;

Wang, Jina ;

Wang, Xuanchuan ;

Qi, Guisheng ;

Rong, Ruiming ;

Xu, Ming ;

Zhu, Tongyu .

BMC PHARMACOLOGY & TOXICOLOGY, 2018, 19

[20] Bioavailability of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium Is Differentially Affected by Pantoprazole in Healthy Volunteers [J].

Rupprecht, Korbinian ;

Schmidt, Christoph ;

Raspe, Anne ;

Schweda, Frank ;

Shipkova, Maria ;

Fischer, Wolfgang ;

Bucher, Michael ;

Kees, Frieder ;

Faerber, Lothar .

JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (10) :1196-1201

← 1 2 3 4 5 →